State Street
ASMB icon

State Street’s Assembly Biosciences ASMB Stock Holding History

State Street’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.57M Buy
56,689
+3,700
+7% +$106K ﹤0.01% 3367
2025
Q4 		$1.8M Buy
52,989
+8,175
+18% +$263K ﹤0.01% 3377
2025
Q3 		$1.15M Buy
44,814
+30,805
+220% +$676K ﹤0.01% 3482
2025
Q2 		$254K Hold
14,009
– – ﹤0.01% 3768
2025
Q1 		$134K Hold
14,009
– – ﹤0.01% 3909
2024
Q4 		$221K Buy
14,009
+1,200
+9% +$19.3K ﹤0.01% 3829
2024
Q3 		$194K Hold
12,809
– – ﹤0.01% 3830
2024
Q2 		$176K Buy
12,809
+700
+6% +$9.98K ﹤0.01% 3857
2024
Q1 		$161K Sell
12,109
-2
-0% -$23 ﹤0.01% 3922
2023
Q4 		$119K Hold
12,111
– – ﹤0.01% 4024
2023
Q3 		$129K Hold
12,111
– – ﹤0.01% 4048
2023
Q2 		$167K Hold
12,111
– – ﹤0.01% 4051
2023
Q1 		$122K Hold
12,111
– – ﹤0.01% 4259
2022
Q4 		$189K Hold
12,111
– – ﹤0.01% 4123
2022
Q3 		$238K Hold
12,111
– – ﹤0.01% 4065
2022
Q2 		$305K Hold
12,111
– – ﹤0.01% 4022
2022
Q1 		$299K Buy
12,111
+1,642
+16% +$35.3K ﹤0.01% 4241
2021
Q4 		$293K Hold
10,469
– – ﹤0.01% 4192
2021
Q3 		$437K Sell
10,469
-3,733
-26% -$156K ﹤0.01% 4029
2021
Q2 		$661K Sell
14,202
-36,859
-72% -$1.83M ﹤0.01% 3759
2021
Q1 		$2.82M Sell
51,061
-1,770
-3% -$117K ﹤0.01% 3294
2020
Q4 		$3.84M Sell
52,831
-45,659
-46% -$5.36M ﹤0.01% 3095
2020
Q3 		$19.4M Buy
98,490
+12,708
+15% +$3.2M ﹤0.01% 2060
2020
Q2 		$24M Buy
85,782
+39,838
+87% +$9.29M ﹤0.01% 1930
2020
Q1 		$8.18M Buy
45,944
+7,135
+18% +$1.53M ﹤0.01% 2390
2019
Q4 		$9.53M Buy
38,809
+1,108
+3% +$204K ﹤0.01% 2551
2019
Q3 		$4.45M Buy
37,701
+461
+1% +$69.7K ﹤0.01% 2846
2019
Q2 		$6.03M Sell
37,240
-30,707
-45% -$5.84M ﹤0.01% 2732
2019
Q1 		$16.1M Buy
67,947
+31,705
+87% +$8.03M ﹤0.01% 2186
2018
Q4 		$9.84M Sell
36,242
-2,045
-5% -$592K ﹤0.01% 2441
2018
Q3 		$17.1M Buy
38,287
+7,980
+26% +$3.74M ﹤0.01% 2285
2018
Q2 		$14.3M Buy
30,307
+6,131
+25% +$3.24M ﹤0.01% 2355
2018
Q1 		$14.3M Buy
24,176
+1,973
+9% +$1.22M ﹤0.01% 2278
2017
Q4 		$12.1M Buy
22,203
+3,505
+19% +$1.59M ﹤0.01% 2377
2017
Q3 		$7.83M Buy
18,698
+1,605
+9% +$492K ﹤0.01% 2557
2017
Q2 		$4.23M Buy
+17,093
New +$4.81M ﹤0.01% 2817
2016
Q2 		– Sell
-13,189
Closed -$799K – 3728
2016
Q1 		$799K Buy
13,189
+1,235
+10% +$82.6K ﹤0.01% 3266
2015
Q4 		$1.08M Buy
11,954
+722
+6% +$78.7K ﹤0.01% 3198
2015
Q3 		$1.29M Buy
11,232
+1,427
+15% +$251K ﹤0.01% 3154
2015
Q2 		$2.27M Buy
+9,805
New +$1.89M ﹤0.01% 3020
2013
Q4 		– Sell
-265
Closed -$45K – 3635
2013
Q3 		$45K Sell
265
-70
-21% -$10.7K ﹤0.01% 3533
2013
Q2 		$48K Buy
+335
New +$52.5K ﹤0.01% 3451

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

State Street's ASMB Position: Q1 2026 in Review

State Street increased its Assembly Biosciences (ASMB) stake by 7% in Q1 2026, buying an estimated $106K and bringing the position to 56,689 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #3367.

State Street first reported a position in ASMB in Q2 2013 and has held it in 42 quarters since. The position peaked at $24M in Q2 2020. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • State Street held 56,689 shares of Assembly Biosciences worth $1.57M as of Q1 2026.
  • State Street bought 3,700 Assembly Biosciences shares in Q1 2026, an estimated $106K.
  • Assembly Biosciences made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3367 holding.
  • State Street first reported a position in Assembly Biosciences in Q2 2013 and has held it in 42 quarters since.
  • State Street's Assembly Biosciences position peaked at $24M in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.